Carlos Panizo

4PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 28, 2023
Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma.

Javier Melchor, Marcos Garcia-Lacarte, Sara C Grijalba

|Jan 19, 2022
Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma.

Sara Rodriguez, Jon Celay, Ibai Goicoechea

|Mar 05, 2020
Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression.

Ascensión López-Díaz de Cerio, Ricardo García-Muñoz, Esther Pena

|Oct 02, 2019
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study.

Ricardo García-Muñoz, Cristina Quero, Ernesto Pérez-Persona

Pageof 1

Frequent Collaborators

2 joint publications

Jose-Angel Martinez-Climent

1 joint publications

Nicolás Martínez-Calle

1 joint publications

Susana Inogés

1 joint publications

Sara Rodriguez